ASHP therapeutic position statement on the use of statins in the prevention of atherosclerotic vascular disease in adults
Elevated blood cholesterol levels contribute significantly to ASVD and are often undertreated or not treated at all. Evaluation and management of lipid disorders should be guided by current NCEP guidelines. For patients with elevated cholesterol levels after appropriate therapeutic lifestyle changes...
Saved in:
Published in | American journal of health-system pharmacy Vol. 60; no. 6; pp. 593 - 598 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
ASHP
15.03.2003
American Society of Health Pharmacists |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Elevated blood cholesterol levels contribute significantly to ASVD and are often undertreated or not treated at all. Evaluation and management of lipid disorders should be guided by current NCEP guidelines. For patients with elevated cholesterol levels after appropriate therapeutic lifestyle changes, statins are a safe and effective means of reducing cardiovascular events. Because of their proven safety and effectiveness, ASHP supports the use of statins as first-line therapy for the primary and secondary prevention of atherosclerotic events. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Instructional Material/Guideline-1 ObjectType-Feature-3 content type line 23 |
ISSN: | 1079-2082 1535-2900 |
DOI: | 10.1093/ajhp/60.6.593 |